Cite Filings / APVO / 0000899140-19-000297
Feed Companies Filings Check
Sign in
SC 13G

Amended Statement of Ownership

Aptevo Therapeutics Inc. · Filed 2019-03-12 · Acc 0000899140-19-000297

Documents 1

  • SC 13G Amended Statement of Ownership , p28604665a.htm

Around this filing

  • 2019-03-18 8-K Results of operations
  • 2019-03-18 SC 13G Amended Statement of Ownership
  • 2019-03-12 SC 13G Amended Statement of Ownership
  • 2019-03-11 8-K Other events
  • 2019-03-08 424B5 Prospectus
  • 2019-03-06 424B5 Prospectus
  • 2019-02-12 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · CVI Investments, Inc. 4.4%
  2. 2026-11-12 SCHEDULE 13G/A · Ayrton Capital LLC 3.72%
  3. 2026-08-14 SCHEDULE 13G/A · CVI Investments, Inc. 6.3%
  4. 2026-06-22 SCHEDULE 13G · NIOWAVE, INC. 12.2%
  5. 2026-02-17 SCHEDULE 13G/A · CVI Investments, Inc. 8.2%
  6. 2026-02-17 SCHEDULE 13G/A · Point72 Asset Management, L.P. 0%
  7. 2025-11-07 SCHEDULE 13G/A · BANK OF AMERICA CORP /DE/ 0.0%
  8. 2025-10-06 SCHEDULE 13G · BANK OF AMERICA CORP /DE/ 15.0%
  9. 2025-09-17 SCHEDULE 13G · Point72 Asset Management, L.P. 9.1%
  10. 2025-08-14 SCHEDULE 13G/A · CVI Investments, Inc. 9.9%
  11. 2025-08-14 SCHEDULE 13G/A · L1 Capital Global Opportunities Master Fund, Ltd. 4.99%
Loading p28604665a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…